Ideagen (IDEA) Sets New 1-Year High at $100.40
Shares of Ideagen PLC (LON:IDEA) hit a new 52-week high on Thursday . The stock traded as high as GBX 100.40 ($1.34) and last traded at GBX 101.50 ($1.36), with a volume of 119754 shares traded. The stock had previously closed at GBX 101.50 ($1.36).
IDEA has been the subject of several recent research reports. FinnCap reissued a “corporate” rating and set a GBX 108 ($1.45) price objective on shares of Ideagen in a report on Tuesday, November 7th. reaffirmed a “corporate” rating and issued a GBX 108 ($1.45) price target on shares of Ideagen in a research note on Tuesday, November 7th.
In related news, insider David Hornsby purchased 2,117 shares of the stock in a transaction dated Monday, October 9th. The stock was bought at an average cost of GBX 85 ($1.14) per share, with a total value of £1,799.45 ($2,409.87). Also, insider Jonathan Wearing sold 100,000 shares of the company’s stock in a transaction dated Tuesday, October 31st. The shares were sold at an average price of GBX 79 ($1.06), for a total value of £79,000 ($105,798.85).
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/02/ideagen-idea-sets-new-1-year-high-at-100-40.html.
Ideagen plc is engaged in the development and sale of information management software to businesses in various industries, and the provision of associated professional services and support. The Company is engaged in supplying governance, risk and compliance (GRC) solutions primarily to the healthcare, transport, aerospace and defense, manufacturing and financial services sectors.
Receive News & Stock Ratings for Ideagen PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ideagen PLC and related stocks with our FREE daily email newsletter.